H30.103
Unspecified disseminated chorioretinal inflammation, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified disseminated chorioretinal inflammation involving both eyes is a condition characterized by widespread inflammation within the choroid and retina of the eyes. This inflammation can affect vision and eye health, presenting a challenge for diagnosis and management. While the exact cause remains unspecified in this diagnosis, understanding the condition’s features, symptoms, and potential approaches to care can help patients and caregivers better grasp the situation.
Causes & Symptoms
Clinical Causes: Autoimmune diseases where the immune system mistakenly attacks eye tissues Infections such as toxoplasmosis, syphilis, tuberculosis, or viral infections Inflammatory conditions linked to systemic illnesses like sarcoidosis or Behçet's disease Previous eye injuries or surgeries that may trigger inflammatory responses Unknown factors or idiopathic cases where no specific cause is identified
Key Symptoms: Blurred or decreased vision in one or both eyes Floaters or spots drifting across the visual field Eye pain or discomfort, particularly with eye movement Sensitivity to light (photophobia) Redness and swelling of the eyes Visual distortions or irregularities In some cases, no obvious symptoms are present, especially in early stages
Diagnostic & Treatment
Diagnosis Path: Visual acuity tests to assess vision clarity Slit-lamp examination to evaluate the front and back parts of the eye Fundus photography and fluorescein angiography to observe retinal and choroidal activity Optical coherence tomography (OCT) imaging for detailed retinal layers Laboratory tests to identify infectious or autoimmune causes, such as blood work or specific antibody tests A detailed medical history to identify systemic diseases or previous health issues
Treatment Protocols: Corticosteroids to reduce inflammation and suppress immune response Immunosuppressive medications in cases linked to autoimmune conditions Antimicrobial therapy if an infectious origin is confirmed Monitoring and follow-up examinations to evaluate response to treatment Supportive measures such as vision aids or low-vision rehabilitation if vision loss occurs Addressing any underlying systemic disease to prevent recurrence or progression
Clinical Advice & FAQs
Billing Guidance
Is H30.103 a billable ICD-10 code?
Yes, H30.103 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H30.103?
Clinical documentation must specify the nature of Unspecified disseminated chorioretinal inflammation, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference